Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Soon Dr. Ichim will deliver IP(Intellectual property) for our subsidiary Regen Pharma. Should get very interesting when the market has something to speculate on. Commercializing Biotech is "big money".
Rescent report released 9/8/2012 http://finance.yahoo.com/q/rr?s=BMSN&t=
My take on the Imenvax update is a disappointing one. Although it slowed tumor growth, It failed to reduce it's size. The good news is it was recommended to continue the study, but the bad news is the expense to Entest for 12 to 14 months. If there is any value for Imenvax it will need to report the reduction of a tumor, not just slowing growth. This is why our shorty friends stuffed us during the "Rally". It will be a long wait from here.
Working capital without increasing the float is a good thing. Looking for an update from Entest that informs shareholders what the capital will be used for.
I understand the excitement! The truth is we are "golden" here. Enjoy! your holiday weekend.
The buisness model described here is absolutely! brilliant. The data collected over time is highly valuble when imenvax becomes a consideration for cancer therapy for humans. The intellectual value of Imenvax "alone" for entest in my opinion is worth a 50 million market cap before any revenue. That would currently price the stock if fully diluted at $0.05 cents.
The only way for this stock reaching that level would only be if IMENVAX has a 60% effecacy rate. Then it would surely get the required attention to advance to humans. As for now the technicals are screaming for the (Golden cross).
This chart is looking like a double bottom. If so, then technically speaking the market will test the recent highs. Slow and steady climb expected.
We are going to get somthing from the sale of equity to southridge, as this is how emerging growth companies build their buisness.
Your order may have been placed as (all or none).It will fill in small lots when (all or none) check mark is removed.
No! not true, they are restricted for one year. The action from vfin is from an outside source.
The filing today was made to register the shares that will be put to Southridge, as this will open the equity purchase agreement. Entest should be droping a news release to inform share holders as to what the purchase plan will be used for. I would like to think that maybe there is an aquisition of another Veternarian hospital in the works.
For what it's worth, I suggest a visit to our veterinary hospital http://www.mcdonaldvet.info/ and notice under services provided (STEM CELL THERAPY). Offering this to the public tells me with "certainty" that we are clearly making progress. GOOD DEAL!
Isn't it interesting how there is big volume at this level. The level that Southridge partners agreement was estimated at for (S1 filing FEE). Someone(or group) is always willing to buy large down here. I raised my share count along with these characters, because! I believe the success of the Imenvax therapy safety studies will be the catlyst that will put this company on Centerstage of the stemcell market for vetrenarians. Looking for the results in february 2013.
Penny stocks get no respect from the major market players. We can only rely on ourselves down here. The penny stock market is a popular place for retail traders, but during the last decade with so much confidence been shaken has seriously blown out the retail trader. This will change when economies around the world begin to stabilize with 2%to5% GDP. Job security and liquidity in the system will go a long way towards rebuilding confidence.
It appeared to me when this stock opened for trading friday the marketeers! decided for some reason that a reversal was in order. They went way out of their way to insure that the stock closed above .0029. In my opinion this should be received as "very" positive, also for what it's worth I would have to say that a positive news development must be very near. The Daytraders will lose complete control over this stock if Safety studies are reported with a high efficacy rate. They will say! (I wish I did'nt SELL)
Nonsense!
The bid will climb if there are no more unhappy! short sellers.
It was always known that entest operates in the red. The value anticipated is with the intellectual value of Imen-vax currently in the safety study stage. If the company can report positive results then the therapy will be eligible for commercilization. This stage will likely be funded by Southridge Partners, Although at this stage the company may be in a very strong negotiating position to get nondilutive capital. It was stated that the company does not expect to put all shares to southridge.
The time frame for Safety Studies is 6 to 9 months. I will wait till then before coming to any definitive conclusions.
Good stuff! Thanks for the info. There will be value here when the company delivers a positive report in regard to the safety studies.
Noticed some large bids on level-2 in .002-.003 range. Daytraders are likely going to accumulate shares at this level. This stock is owned by Daytraders until the company can deliver on the next development.
I agree with you that posts should be received with a grain of salt. I did say that message boards are just a good "tool" in my previous post. There are "credible" posters that are long term investors posting facts! that are backed by news articles, or SEC. filings.
It has always been clear to me what Entest has for Its intellectual property. This was evident then, and is evident now. The timing was wrong early on, because Dr. Koos made a decision to take the fast track by financing with venture capitalist Southridge partners. Unfortunately! for early investors the deal struck with Southridge requiered share restructuring. Very shortly after the new share structure was filed with the SEC, I noticed the share price stabilize and begin to climb. We are on track right now and await further developments.
Yea! I agree, a message board is a good tool to measure the sentement of an underlying company and its management.
http://www.watervilleresearch.com/entest/
Here is a link to an earlier research report that lays out the buisness plan for Entest Biomedical. It appears to still be on track.
The new flag formation taking place over the last few days is trending up. A clear signal that the price is more likely now to begin a positive climb to recent highs. Current share holders are long! and strong!.
I recommend not quiting! your job until you have reached at least $25k. This will put you at the Daytrader status. Have you learned the secret to Daytrading, because if not now would be a good time.
Nice post here! "Good job", and Thanks for the info.
Thanks! for the rassional remarks. In due time the safety study results for Imen-Vax will be made public causing a sharp rally, as the market will be pricing in the value of the commercilization of Imen-Vax.
Yea! It seems that most uptrends begin with speculation, that is followed with confirmation from a statement by the company. The price could still uptrend quietly without an update on low volume that could surprise with a quick snap to recent highs.
Aniemic volume day today! All this means is that the swing Daytraders have stepped away for now. The price range for entest is likely to remain above the 50-DMA. If the chart begins to form a new flag formation that trends up, Then I would expect Daytrader participation to pickup. This is the point in a Bullish move that "tests" the strength of the long term holders. If the long term holders are weak here, then we will likely experience a slow bleed on aniemic volume that will find support at the 50-DMA. WE will soon have an update from the company that will change the trading conditions that we have right now.
The shares will need to be registered prior to any delivery to southridge.
What a PUNY! turtle ...LoL
Southridge has not received the shares that you are refering to, they are on standby. It is very likely that they will not sell them at this level.
What a nice surprise! today. This was validation for being long term, and builds confidence. Did anyone notice the positive action in Bio-matrix, it might mean positive developments are very near in all of Dr. koos's entities.
I noticed today that our unloved shorty market maker left the L2 board around 2:30. They will probrobly allow the daily price movement to remain between the 50 and 100 DMA. That is unless we get a corporate update that contains details on the companies progress. The ball is in the Ceo's court now. We experienced speculation! with this recent rally, and it was a dead cat bounce from the higher levels. Only a one time sell off will sort this out in favor of the Fundies.
Yea! The southridge financing will expire shortly there after. This window could change with new developments.
I meant no harm with that comment. I am not in the red yet!, and decided to be long term until february 2013.
For what its worth, there are much smaller profits to protect at this level. This level should be short lived.